Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(12 sites)

Belgium

UZA, Edegem, Antwerpen

Hôpital des enfants Reine Fabiola, Brussels, Brabant

AZ VUB Jette, Brussels, Brabant

Cliniques universitaires Saint-Luc- Université Catholique de Louvain, Brussels, Brabant

AZ Gasthuisberg Leuven, Leuven, Flamish Brabant

UZ Gent, Ghent, Flanders Ost

Hôpital de Jolimont, Haine-Saint-Paul, Hainaut

Cliniques Universitaires Mont-Godinne, Yvoir, Namur

AZ St Jan, Bruges, West Flanders

Hôpital Stuyvenberg, Antwerp

CHU Sart Tilman, Liège

Netherlands

University Hospital Maastricht, Maastricht, Limburg